Pages that link to "Q61960641"
Jump to navigation
Jump to search
The following pages link to The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies (Q61960641):
Displaying 50 items.
- cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia (Q24550819) (← links)
- New concepts of resistance in the treatment of Helicobacter pylori infections (Q24622513) (← links)
- H pylori antibiotic resistance: prevalence, importance, and advances in testing (Q24685864) (← links)
- Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions (Q26778023) (← links)
- Effect of acid secretion blockade by omeprazole on the relative bioavailability of orally administered furazolidone in healthy volunteers (Q28345560) (← links)
- Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment (Q28348595) (← links)
- Helicobacter pylori-Associated Diseases (Q30310223) (← links)
- Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations (Q31138535) (← links)
- Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review (Q31955396) (← links)
- Oxidases and reductases are involved in metronidazole sensitivity in Helicobacter pylori (Q32151368) (← links)
- Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance (Q33639114) (← links)
- Comparison of five-day Helicobacter pylori eradication regimens: rabeprazole-based and omeprazole-based regimens with and without omeprazole pretreatment (Q33739015) (← links)
- Helicobacter pylori eradication in patients with non-ulcer dyspepsia (Q33793191) (← links)
- Regular review: treatment of Helicobacter pylori infection (Q33807123) (← links)
- Unique mechanism of Helicobacter pylori for colonizing the gastric mucus. (Q33863054) (← links)
- Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay (Q33974794) (← links)
- Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study (Q33978090) (← links)
- Finding the optimum treatment for Helicobacter pylori (Q34024761) (← links)
- Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease (Q34031401) (← links)
- How to treat Helicobacter pylori. First-line, second-line, and future therapies (Q34145476) (← links)
- An update on Helicobacter pylori microbiology and infection for the new millennium. (Q34219944) (← links)
- Treatment of Helicobacter pylori (Q34512048) (← links)
- Treatment of Helicobacter pylori infection. Indications and regimens: an update (Q34583340) (← links)
- Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin (Q34604699) (← links)
- Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy (Q34722715) (← links)
- Indications for Helicobacter pylori eradication therapy and first-line therapy regimen in Japan: recommendation by the Japanese Society for Helicobacter Research (Q34730175) (← links)
- Peptic-ulcer disease (Q34921684) (← links)
- Antibiotic resistance of Helicobacter pylori strains in Japanese children (Q34946883) (← links)
- Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial (Q35009862) (← links)
- Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model (Q35102815) (← links)
- A clinical practice viewpoint: to culture or not to culture Helicobacter pylori? (Q35170767) (← links)
- Diagnostic methods for Helicobacter pylori detection and eradication (Q35200053) (← links)
- Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: A pilot study (Q35539764) (← links)
- Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study (Q35761431) (← links)
- The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention (Q36012984) (← links)
- Which Therapy for Helicobacter pylori Infection? (Q36060733) (← links)
- Diagnostic accuracy of a rapid fecal test to confirm H pylori eradication after therapy: prospective comparison with a laboratory stool test (Q36179068) (← links)
- Follow up of serial urea breath test results in patients after consumption of antibiotics for non-gastric infections. (Q36308218) (← links)
- Trends in the eradication rates of Helicobacter pylori infection for eleven years (Q36450494) (← links)
- Review article: the opportunities and benefits of extended acid suppression (Q36478875) (← links)
- Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study) (Q36491981) (← links)
- Molecular and Proteomic Analysis of Levofloxacin and Metronidazole Resistant Helicobacter pylori (Q37505662) (← links)
- Long-term pretreatment with proton pump inhibitor and Helicobacter pylori eradication rates (Q37578697) (← links)
- Current recommendations for Helicobacter pylori therapies in a world of evolving resistance (Q37591509) (← links)
- Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea (Q37624449) (← links)
- Acid peptic diseases: pharmacological approach to treatment (Q37913063) (← links)
- Biofilms and Helicobacter pylori: Dissemination and persistence within the environment and host. (Q38240874) (← links)
- Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection (Q38951065) (← links)
- In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori (Q39474501) (← links)
- The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin (Q42023922) (← links)